Karmelsonix Limited - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Karmelsonix Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Karmelsonix Limited Formerly known as Salus Technologies Limited. The Group's principal activities are researching, developing and commercialising medical devices. Its products primarily include non-invasive clinical solutions for patients with cardio-pulmonary disorders such as asthma, congestive heart failure (CHF), acute respiratory distress syndrome (ARDS), obstructive sleep apnea (OSA), emphysema, and chronic obstructive pulmonary disease (COPD). The Group acquired PulmoSonix Ltd and Karmel Sonix (Israel) Ltd in 21 November 2006 and disposed of its interest in Advanced Wound Care Pty Ltd in 14 December 2006. It operates in Australia and Israel.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report